Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- befree-2016 importedOn "2016-02-19" NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_assertion wasGeneratedBy ECO_0000203 NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_assertion wasDerivedFrom befree-2016 NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_assertion SIO_000772 10360828 NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_assertion evidence source_evidence_literature NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.
- NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_assertion description "[Our findings suggest that while anti-P-gp Abs had antimetastatic potential against SCLC cells expressing P-gp, combined treatment with M-CSF gene transduction to augment the therapeutic efficacy of anti-P-gp Abs may be beneficial for eradicating metastatic MDR SCLC in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254322.RAcf6U9-cHwoq70JzrmRgMHBqPgX1iXvwhhijDNDlh2zY130_provenance.